These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

168 related articles for article (PubMed ID: 9480267)

  • 1. [Results of the SYST-EUR study. Isolated systolic hypertension and calcium antagonists].
    Faulhaber HD
    Fortschr Med; 1997 Nov; 115(32):45-6. PubMed ID: 9480267
    [No Abstract]   [Full Text] [Related]  

  • 2. Hydrochlorothiazide, atenolol, nitrendipine, and enalapril in antihypertensive treatment. Influence on LVH, proteinuria and metabolic parameters. The HANE Trial Research Group.
    Kribben A; Anlauf M; Distler A; Gärtner H; Holzgreve H; Michaelis J; Röcker L; Schäfers R; Philipp U; Wellek S; Philipp T
    Kidney Int Suppl; 1997 Oct; 61():S74-6. PubMed ID: 9328972
    [No Abstract]   [Full Text] [Related]  

  • 3. Antihypertensive treatment and CHD in the elderly.
    Fink KS; Ellsworth A
    Am Fam Physician; 1999 Sep; 60(4):1102, 1104, 1107. PubMed ID: 10507742
    [No Abstract]   [Full Text] [Related]  

  • 4. Systolic hypertension.
    Smith WM
    Curr Ther Endocrinol Metab; 1994; 5():590-2. PubMed ID: 7704800
    [No Abstract]   [Full Text] [Related]  

  • 5. [Antihypertensive treatment and prevention of dementia].
    Seux ML
    Ann Cardiol Angeiol (Paris); 1999 Sep; 48(7):512-7. PubMed ID: 12555375
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Cardiovascular events in elderly patients with isolated systolic hypertension. A subgroup analysis of treatment strategies in STOP-Hypertension-2.
    Ekbom T; Linjer E; Hedner T; Lanke J; De Faire U; Wester PO; Dahlöf B; Scherstén B
    Blood Press; 2004; 13(3):137-41. PubMed ID: 15223721
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Randomised double-blind comparison of placebo and active treatment for older patients with isolated systolic hypertension. The Systolic Hypertension in Europe (Syst-Eur) Trial Investigators.
    Staessen JA; Fagard R; Thijs L; Celis H; Arabidze GG; Birkenhäger WH; Bulpitt CJ; de Leeuw PW; Dollery CT; Fletcher AE; Forette F; Leonetti G; Nachev C; O'Brien ET; Rosenfeld J; Rodicio JL; Tuomilehto J; Zanchetti A
    Lancet; 1997 Sep; 350(9080):757-64. PubMed ID: 9297994
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Trials in elderly patients with isolated systolic hypertension.
    Staessen J; Guo C; Celis H; Fagard R; Thijs L; Amery A
    Chin Med J (Engl); 1992 May; 105(5):364-8. PubMed ID: 1499364
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Effects of antihypertensive drug treatment on the risk of dementia and cognitive impairment.
    Poon IO
    Pharmacotherapy; 2008 Mar; 28(3):366-75. PubMed ID: 18294116
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Benazepril plus amlodipine or hydrochlorothiazide for hypertension.
    Strauss MH; Weinstein J; Newton GE
    N Engl J Med; 2009 Mar; 360(11):1148; author reply 1149-50. PubMed ID: 19283888
    [No Abstract]   [Full Text] [Related]  

  • 11. The prevention of dementia with antihypertensive treatment: new evidence from the Systolic Hypertension in Europe (Syst-Eur) study.
    Forette F; Seux ML; Staessen JA; Thijs L; Babarskiene MR; Babeanu S; Bossini A; Fagard R; Gil-Extremera B; Laks T; Kobalava Z; Sarti C; Tuomilehto J; Vanhanen H; Webster J; Yodfat Y; Birkenhäger WH;
    Arch Intern Med; 2002 Oct; 162(18):2046-52. PubMed ID: 12374512
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Follow-up of renal function in treated and untreated older patients with isolated systolic hypertension. Systolic Hypertension in Europe (Syst-Eur) Trial Investigators.
    Voyaki SM; Staessen JA; Thijs L; Wang JG; Efstratopoulos AD; Birkenhäger WH; de Leeuw PW; Leonetti G; Nachev C; Rodicio JL; Tuomilehto J; Fagard R;
    J Hypertens; 2001 Mar; 19(3):511-9. PubMed ID: 11288822
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Dihydropyridine calcium-channel blockers for antihypertensive treatment in older patients--evidence from the Systolic Hypertension in Europe Trial.
    Staessen JA; Thijs L; Celis H; Gasowski J; Wang JG; Fagard RH;
    S Afr Med J; 2001 Dec; 91(12):1060-8. PubMed ID: 11845604
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Effects of a fixed-dose ACE inhibitor-diuretic combination on ambulatory blood pressure and arterial properties in isolated systolic hypertension.
    Ferguson JM; Minas J; Siapantas S; Komesaroff PA; Sudhir K
    J Cardiovasc Pharmacol; 2008 Jun; 51(6):590-5. PubMed ID: 18520951
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Combination therapy with amlodipine/benazapril (CCB/ACEI) superior to hydrochlorothiazide/benazapril in high-risk hypertensive patients.
    Cardiovasc J Afr; 2008; 19(3):163. PubMed ID: 18568181
    [No Abstract]   [Full Text] [Related]  

  • 16. Angiotensin converting enzyme inhibition and dihydropyridine calcium channel blockade in the treatment of left ventricular hypertrophy in arterial hypertension.
    Palmieri V; Devereux RB
    Minerva Cardioangiol; 2002 Jun; 50(3):169-74. PubMed ID: 12107398
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Hypotensive effectiveness of therapy combined enalapril and nitrendipine and influence on the quality of life].
    Bryl W; Cymerys M; Kujawska-Luczak M; Pupek-Musialik D
    Pol Merkur Lekarski; 2005 Mar; 18(105):287-90. PubMed ID: 15997634
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Initial angiotensin-converting enzyme inhibitor/calcium channel blocker combination therapy achieves superior blood pressure control compared with calcium channel blocker monotherapy in patients with stage 2 hypertension.
    Jamerson KA; Nwose O; Jean-Louis L; Schofield L; Purkayastha D; Baron M
    Am J Hypertens; 2004 Jun; 17(6):495-501. PubMed ID: 15177521
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Not all antihypertensive agents protect equally well].
    MMW Fortschr Med; 2006 Aug; 148(33-34):52. PubMed ID: 16981390
    [No Abstract]   [Full Text] [Related]  

  • 20. Effects of antihypertensive treatment on endpoints in the diabetic patients randomized in the Systolic Hypertension in Europe (Syst-Eur) trial.
    Birkenhäger WH; Staessen JA; Gasowski J; de Leeuw PW
    J Nephrol; 2000; 13(3):232-7. PubMed ID: 10928302
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.